id | C00003618 |
---|---|
Name | Digoxin |
CAS RN | 20830-75-5 |
Standard InChI | InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19?,20?,21?,23-,24+,25-,26-,27+,28+,29-,30+,31-,33+,34-,35-,36?,37-,38?,39+,40+,41+/m1/s1 |
Standard InChI (Main Layer) | InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3 |
Phytochemical cluster | No. 56 |
---|---|
KCF-S cluster | No. 272 |
By standard InChI | |
---|---|
By standard InChI Main Layer | CHEMBL1751 CHEMBL1477182 CHEMBL1512361 |
By LinkDB | C06956 |
---|
By CAS RN | D004077 |
---|
class name | count |
---|---|
asterids | 2 |
family name | count |
---|---|
Plantaginaceae | 2 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Digitalis lanata | 49450 | Plantaginaceae | asterids | Viridiplantae |
Digitalis orientalis | 4163 | Plantaginaceae | asterids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL1751 CHEMBL1477182 |
CHEMBL1741321
(1)
CHEMBL1909136
(2)
CHEMBL2071965 (1) |
1 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL1751 CHEMBL1477182 |
CHEMBL1613992
(2)
CHEMBL1613995
(2)
CHEMBL2114895 (1) |
7 / 44 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL1477182 CHEMBL1512361 |
CHEMBL1613842
(2)
|
4 / 2 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | CHEMBL1751 |
CHEMBL2169429
(1)
|
1 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | CHEMBL1751 |
CHEMBL2169431
(1)
|
0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL1477182 |
CHEMBL2114784
(1)
|
1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL1751 |
CHEMBL1794499
(1)
|
2 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL1751 |
CHEMBL1909139
(2)
|
0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | CHEMBL1751 |
CHEMBL965575
(1)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL1751 |
CHEMBL1909131
(2)
|
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL1751 |
CHEMBL1909190
(2)
|
2 / 2 |
P01375 | Tumor necrosis factor | Secreted protein | CHEMBL1751 |
CHEMBL2114889
(1)
|
3 / 6 |
P08246 | Neutrophil elastase | S1A | CHEMBL1751 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL1751 |
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL1751 |
CHEMBL1909201
(2)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL1751 |
CHEMBL1909176
(2)
|
0 / 0 |
P29466 | Caspase-1 | C14 | CHEMBL1751 |
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL1751 |
CHEMBL1909198
(2)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL1751 |
CHEMBL1909199
(2)
|
0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | CHEMBL1751 |
CHEMBL1794524
(2)
CHEMBL1794552
(2)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL1751 |
CHEMBL1909197
(2)
|
2 / 2 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | CHEMBL1751 |
CHEMBL993349
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL1751 CHEMBL1477182 |
CHEMBL1614544
(3)
|
11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL1477182 |
CHEMBL1614361
(1)
|
3 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL1751 |
CHEMBL1794399
(2)
CHEMBL1794561
(1)
|
3 / 1 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | CHEMBL1751 |
CHEMBL1794371
(2)
CHEMBL1794471
(2)
|
0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL1751 |
CHEMBL1909123
(2)
|
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL1751 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL1751 |
CHEMBL965569
(1)
CHEMBL965573
(1)
CHEMBL1909169 (2) |
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL1751 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL1751 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL1751 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL1751 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL1751 |
CHEMBL1909090
(2)
|
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL1751 |
CHEMBL1909093
(2)
|
0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL1751 |
CHEMBL755826
(1)
CHEMBL755827
(1)
CHEMBL754160 (1) CHEMBL754161 (1) CHEMBL1743157 (1) CHEMBL2077111 (1) CHEMBL2077420 (1) CHEMBL2077421 (1) CHEMBL2076098 (1) CHEMBL2076099 (1) CHEMBL2076268 (1) CHEMBL2076278 (1) CHEMBL2076683 (1) CHEMBL2076703 (1) CHEMBL2076852 (1) CHEMBL2077017 (1) CHEMBL2077347 (1) CHEMBL2075195 (1) CHEMBL2075438 (1) CHEMBL2076207 (1) CHEMBL2076209 (1) CHEMBL2076241 (1) CHEMBL2076251 (1) CHEMBL2076044 (1) |
1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL1751 |
CHEMBL1909127
(2)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL1751 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL1751 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1751 CHEMBL1477182 |
CHEMBL1741325
(1)
CHEMBL1909135
(2)
CHEMBL2071963 (1) |
0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL1751 |
CHEMBL1909203
(2)
|
1 / 11 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL1751 |
CHEMBL1794376
(2)
|
2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL1751 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL1751 |
CHEMBL1909130
(2)
|
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL1751 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL1751 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL1751 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL1751 |
CHEMBL1909214
(2)
|
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL1751 |
CHEMBL1909175
(2)
|
0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL1751 |
CHEMBL1909096
(2)
|
1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL1751 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL1751 |
CHEMBL1909166
(2)
|
1 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL1751 |
CHEMBL1909133
(2)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL1477182 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL1751 |
CHEMBL1794584
(1)
|
2 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL1751 |
CHEMBL2114843
(3)
CHEMBL2114780
(3)
|
0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | CHEMBL1751 |
CHEMBL1613838
(2)
|
0 / 0 |
P46721 | Solute carrier organic anion transporter family member 1A2 | Unclassified protein | CHEMBL1751 |
CHEMBL1743150
(1)
|
0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL1751 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL1751 |
CHEMBL1909088
(2)
|
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL1751 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL1751 |
CHEMBL1909101
(2)
|
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL1751 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL1751 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL1751 |
CHEMBL1909146
(2)
|
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL1751 |
CHEMBL1909104
(2)
|
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL1751 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL1751 |
CHEMBL1909100
(2)
|
0 / 0 |
P10145 | Interleukin-8 | Secreted protein | CHEMBL1751 |
CHEMBL2114835
(1)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL1751 |
CHEMBL1909167
(2)
|
1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL1751 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL1751 |
CHEMBL1909194
(2)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL1751 |
CHEMBL1909110
(2)
|
1 / 0 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | CHEMBL1751 |
CHEMBL1614133
(1)
|
1 / 2 |
P03956 | Interstitial collagenase | M10A | CHEMBL1751 |
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL1751 |
CHEMBL1909119
(2)
|
0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | CHEMBL1751 |
CHEMBL1743146
(1)
CHEMBL2076238
(1)
CHEMBL2169430 (1) |
1 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL1751 |
CHEMBL1794382
(2)
CHEMBL1794456
(1)
CHEMBL1909150 (2) |
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL1751 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL1751 |
CHEMBL1909170
(2)
|
0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL1751 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL1751 |
CHEMBL1909109
(2)
|
2 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL1751 |
CHEMBL1794293
(2)
CHEMBL1794510
(2)
|
5 / 3 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL1751 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL1751 |
CHEMBL1909172
(2)
|
1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL1751 |
CHEMBL1909114
(2)
|
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL1751 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL1751 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL1751 |
CHEMBL1909108
(2)
|
0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | CHEMBL1751 |
CHEMBL1614217
(1)
|
1 / 1 |
Q96RI1 | Bile acid receptor | NR1H4 | CHEMBL1751 |
CHEMBL1794415
(1)
CHEMBL1794437
(2)
|
0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL1751 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL1751 |
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL1751 |
CHEMBL1909207
(2)
|
2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL1751 CHEMBL1477182 |
CHEMBL1741322
(1)
CHEMBL1909132
(2)
CHEMBL2071962 (1) |
0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | CHEMBL1751 |
CHEMBL1006005
(1)
|
1 / 1 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | CHEMBL1751 |
CHEMBL1614342
(2)
|
1 / 1 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | CHEMBL1751 |
CHEMBL2114842
(1)
CHEMBL2327511
(1)
|
0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL1751 |
CHEMBL1738588
(2)
|
0 / 0 |
P21439 | Multidrug resistance protein 3 | Enzyme | CHEMBL1751 |
CHEMBL1743163
(1)
|
3 / 2 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL1751 |
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL1751 |
CHEMBL1794364
(2)
CHEMBL1794542
(1)
CHEMBL1909145 (2) |
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL1751 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL1751 |
CHEMBL1909212
(2)
|
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL1751 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL1751 |
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL1751 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL1751 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL1751 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL1751 |
CHEMBL1909187
(2)
|
0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL1751 |
CHEMBL1909168
(2)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1751 CHEMBL1477182 |
CHEMBL1741323
(1)
CHEMBL1909134
(2)
CHEMBL2071964 (1) |
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1751 CHEMBL1477182 |
CHEMBL664809
(1)
CHEMBL1741324
(1)
CHEMBL1909138 (2) CHEMBL2071966 (1) CHEMBL2071967 (1) |
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL1751 |
CHEMBL1909137
(2)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL1751 |
CHEMBL1614211
(1)
|
0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL1751 |
CHEMBL1738184
(1)
CHEMBL2114890
(2)
|
0 / 0 |
P10275 | Androgen receptor | NR3C4 | CHEMBL1751 |
CHEMBL1794321
(2)
CHEMBL1794560
(1)
|
3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL1751 |
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL1751 |
CHEMBL1909087
(2)
|
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL1751 |
CHEMBL1909213
(2)
|
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL1751 |
CHEMBL1909089
(2)
|
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL1751 |
CHEMBL1909116
(2)
|
1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL1751 |
CHEMBL1909206
(2)
|
0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL1751 |
CHEMBL1909128
(2)
|
0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | CHEMBL1751 |
CHEMBL1613829
(1)
|
0 / 0 |
P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | CHEMBL1751 |
CHEMBL1614313
(1)
|
3 / 3 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL1751 |
CHEMBL2354311
(1)
|
1 / 0 |
Q6ZQN7 | Solute carrier organic anion transporter family member 4C1 | Unclassified protein | CHEMBL1751 |
CHEMBL2076885
(1)
CHEMBL2075763
(1)
|
0 / 0 |
Q9NYB5 | Solute carrier organic anion transporter family member 1C1 | Unclassified protein | CHEMBL1751 |
CHEMBL2076222
(1)
|
0 / 0 |
Q86UW1 | Organic solute transporter subunit alpha | Unclassified protein | CHEMBL1751 |
CHEMBL2078563
(1)
|
0 / 0 |
P05023 | Sodium/potassium-transporting ATPase subunit alpha-1 | Hydrolase | CHEMBL1751 |
CHEMBL751509
(1)
|
0 / 0 |
P14415 | Sodium/potassium-transporting ATPase subunit beta-2 | potassium_sodium | CHEMBL1751 |
CHEMBL751509
(1)
|
0 / 0 |
P13637 | Sodium/potassium-transporting ATPase subunit alpha-3 | Hydrolase | CHEMBL1751 |
CHEMBL751509
(1)
|
2 / 1 |
Q13733 | Sodium/potassium-transporting ATPase subunit alpha-4 | Hydrolase | CHEMBL1751 |
CHEMBL751509
(1)
|
0 / 0 |
P54710 | Sodium/potassium-transporting ATPase subunit gamma | potassium_sodium | CHEMBL1751 |
CHEMBL751509
(1)
|
1 / 1 |
P54709 | Sodium/potassium-transporting ATPase subunit beta-3 | potassium_sodium | CHEMBL1751 |
CHEMBL751509
(1)
|
0 / 0 |
P50993 | Sodium/potassium-transporting ATPase subunit alpha-2 | Hydrolase | CHEMBL1751 |
CHEMBL751509
(1)
|
2 / 2 |
P05026 | Sodium/potassium-transporting ATPase subunit beta-1 | potassium_sodium | CHEMBL1751 |
CHEMBL751509
(1)
|
0 / 0 |
Q06710 | Paired box protein Pax-8 | Unclassified protein | CHEMBL1751 |
CHEMBL2354301
(1)
|
1 / 2 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D004077 | 10351 |
ABCA8
|
ATP-binding cassette, sub-family A (ABC1), member 8 | Digoxin inhibits the reaction [ABCA8 protein results in increased uptake of estradiol-17 beta-glucuronide] |
decreases reaction
/ increases uptake |
protein |
12379217
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [Digoxin results in increased expression of ABCB1 protein] |
decreases reaction
/ increases expression |
protein |
19647009
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Digoxin results in increased expression of ABCB1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
19647009
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Digoxin results in increased expression of ABCB1 protein] |
decreases reaction
/ increases expression |
protein |
19647009
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | ABCB1 gene SNP affects the abundance of Digoxin |
affects abundance
|
gene |
21311904
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | ABCB1 protein affects the transport of Digoxin |
affects transport
|
protein |
15969931
19505989 |
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | ABCB1 protein binds to and affects the metabolism of Digoxin |
affects binding
/ affects metabolic processing |
protein |
15856409
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | ABCB1 protein results in decreased uptake of Digoxin |
decreases uptake
|
protein |
10617675
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | ABCB1 protein results in increased export of Digoxin |
increases export
|
protein |
16674925
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | ABCB1 protein results in increased transport of Digoxin |
increases transport
|
protein |
10527640
11231118 11895100 16221533 16671962 |
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Amiodarone inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11231118
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | azelastine inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11231118
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | benidipine inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11895100
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Bepridil inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11895100
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Bisoprolol inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
16671962
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Capsaicin affects the reaction [ABCB1 protein results in increased export of Digoxin] |
affects reaction
/ increases export |
protein |
16674925
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | carvedilol inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11895100
16671962 |
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | desethylamiodarone inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11231118
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | desmethylazelastine inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11231118
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Diazinon affects the reaction [ABCB1 protein results in increased transport of Digoxin] |
affects reaction
/ increases transport |
protein |
16221533
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Digoxin inhibits the reaction [ABCB1 protein results in increased transport of quinidinium] |
decreases reaction
/ increases transport |
protein |
23104431
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Digoxin results in increased expression of ABCB1 mRNA |
increases expression
|
mRNA |
19647009
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Digoxin results in increased expression of ABCB1 protein |
increases expression
|
protein |
19647009
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | [Digoxin results in increased expression of ABCB1] which results in decreased susceptibility to Doxorubicin |
decreases response to substance
/ increases expression |
19647009
|
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Diltiazem inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11895100
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Doxazosin inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11895100
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | efonidipine inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11895100
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Itraconazole inhibits the reaction [ABCB1 protein affects the transport of Digoxin] |
affects transport
/ decreases reaction |
protein |
15969931
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Ketoconazole inhibits the reaction [ABCB1 protein affects the transport of Digoxin] |
affects transport
/ decreases reaction |
protein |
15969931
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | KN 93 inhibits the reaction [Digoxin results in increased expression of ABCB1 protein] |
decreases reaction
/ increases expression |
protein |
19647009
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | manidipine inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11895100
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | mepirodipine inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11895100
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Nicardipine inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11895100
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | nilvadipine inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11895100
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Nisoldipine inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
11895100
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Propranolol inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
16671962
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | valspodar inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
16671962
|
D004077 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
decreases reaction
/ increases transport |
protein |
10527640
11895100 |
D004077 | 9429 |
ABCG2
ABC15 ABCP BCRP BCRP1 BMDP CD338 CDw338 EST157481 GOUT1 MRX MXR MXR1 UAQTL1 |
ATP-binding cassette, sub-family G (WHITE), member 2 | Digoxin results in decreased activity of ABCG2 protein |
decreases activity
|
protein |
15365089
|
D004077 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Digoxin results in decreased expression of CCL2 protein |
decreases expression
|
protein |
20116850
|
D004077 | 6351 |
CCL4
ACT2 AT744.1 G-26 HC21 LAG-1 LAG1 MIP-1-beta MIP1B MIP1B1 SCYA2 SCYA4 |
chemokine (C-C motif) ligand 4 | Digoxin results in decreased expression of CCL4 protein |
decreases expression
|
protein |
20116850
|
D004077 | 6352 |
CCL5
D17S136E RANTES SCYA5 SIS-delta SISd TCP228 eoCP |
chemokine (C-C motif) ligand 5 | Digoxin results in decreased expression of CCL5 protein |
decreases expression
|
protein |
20116850
|
D004077 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [Digoxin affects the localization of HIF1A protein] |
affects localization
/ decreases reaction |
protein |
19647009
|
D004077 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [Digoxin results in increased phosphorylation of HIF1A protein] |
decreases reaction
/ increases phosphorylation |
protein |
19647009
|
D004077 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Digoxin affects the localization of HIF1A protein] |
affects localization
/ decreases reaction |
protein |
19647009
|
D004077 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Digoxin affects the localization of HIF1A protein |
affects localization
|
protein |
19647009
|
D004077 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Digoxin results in increased activity of HIF1A protein |
increases activity
|
protein |
19647009
|
D004077 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Digoxin results in increased phosphorylation of and results in increased expression of HIF1A protein |
increases expression
/ increases phosphorylation |
protein |
19647009
|
D004077 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | KN 93 inhibits the reaction [Digoxin affects the localization of HIF1A protein] |
affects localization
/ decreases reaction |
protein |
19647009
|
D004077 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | KN 93 inhibits the reaction [Digoxin results in increased phosphorylation of HIF1A protein] |
decreases reaction
/ increases phosphorylation |
protein |
19647009
|
D004077 | 3570 |
IL6R
CD126 IL-6R-1 IL-6RA IL6Q IL6RA IL6RQ gp80 |
interleukin 6 receptor | Digoxin results in decreased expression of IL6R protein modified form |
decreases expression
|
protein |
20116850
|
D004077 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Digoxin results in decreased expression of IL8 protein |
decreases expression
|
protein |
20116850
|
D004077 | 3630 |
INS
IDDM2 ILPR IRDN MODY10 |
insulin | INS protein results in decreased susceptibility to Digoxin |
decreases response to substance
|
protein |
22562035
|
D004077 | 3757 |
KCNH2
ERG1 HERG HERG1 Kv11.1 LQT2 SQT1 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 | Astemizole inhibits the reaction [Digoxin results in decreased activity of KCNH2 protein] |
decreases activity
/ decreases reaction |
protein |
19139152
|
D004077 | 3757 |
KCNH2
ERG1 HERG HERG1 Kv11.1 LQT2 SQT1 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 | Astemizole inhibits the reaction [Digoxin results in decreased metabolism of KCNH2 protein modified form] |
decreases metabolic processing
/ decreases reaction |
protein |
19139152
|
D004077 | 3757 |
KCNH2
ERG1 HERG HERG1 Kv11.1 LQT2 SQT1 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 | Digoxin results in decreased activity of KCNH2 protein |
decreases activity
|
protein |
19139152
|
D004077 | 3757 |
KCNH2
ERG1 HERG HERG1 Kv11.1 LQT2 SQT1 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 | Digoxin results in decreased expression of KCNH2 protein modified form |
decreases expression
|
protein |
19139152
|
D004077 | 3757 |
KCNH2
ERG1 HERG HERG1 Kv11.1 LQT2 SQT1 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 | KCNH2 gene affects the susceptibility to Digoxin |
affects response to substance
|
gene |
19139152
|
D004077 | 3757 |
KCNH2
ERG1 HERG HERG1 Kv11.1 LQT2 SQT1 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 | Sodium deficiency inhibits the reaction [Digoxin results in decreased expression of KCNH2 protein] |
decreases expression
/ decreases reaction |
protein |
19139152
|
D004077 | 4879 |
NPPB
BNP |
natriuretic peptide B | Digoxin results in increased expression of NPPB protein |
increases expression
|
protein |
16032632
|
D004077 | 6580 |
SLC22A1
HOCT1 OCT1 oct1_cds |
solute carrier family 22 (organic cation transporter), member 1 | Digoxin inhibits the reaction [SLC22A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
decreases reaction
/ increases uptake |
protein |
21641380
|
D004077 | 6581 |
SLC22A3
EMT EMTH OCT3 |
solute carrier family 22 (organic cation transporter), member 3 | Digoxin inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
decreases reaction
/ increases uptake |
protein |
21641380
|
D004077 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | Digoxin results in decreased expression of VEGFA protein |
decreases expression
|
protein |
20116850
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#104290 | Alternating hemiplegia of childhood 1; ahc1 |
P50993
|
#614820 | Alternating hemiplegia of childhood 2; ahc2 |
P13637
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#614972 | Cholestasis, intrahepatic, of pregnancy 3; icp3 |
P21439
|
#602347 | Cholestasis, progressive familial intrahepatic, 3; pfic3 |
P21439
|
#114500 | Colorectal cancer; crc |
P84022
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#128235 | Dystonia 12; dyt12 |
P13637
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600803 | Gallbladder disease 1; gbd1 |
P21439
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#610424 | Hepatitis b virus, susceptibility to |
P01375
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#154020 | Hypomagnesemia 2, renal; homg2 |
P54710
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#218700 | Hypothyroidism, congenital, nongoitrous, 2; chng2 |
Q06710
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#611162 | Malaria, susceptibility to |
P01375
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#602481 | Migraine, familial hemiplegic, 2; fhm2 |
P50993
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#607507 | Psoriatic arthritis, susceptibility to |
P01375
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00079 | Asthma |
P01375
(related)
P07550 (related) |
H00080 | Systemic lupus erythematosus |
P01375
(related)
P01375 (marker) |
H00083 | Allograft rejection |
P01375
(related)
|
H00084 | Graft-versus-host disease |
P01375
(related)
P01375 (marker) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) Q06710 (related) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00831 | Primary dystonia |
P13637
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
Q06710 (related) |
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00624 | Familial cholestasis |
P21439
(related)
|
H01213 | Gallbladder disease |
P21439
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00775 | Familial or sporadic hemiplegic migraine |
P50993
(related)
|
H00998 | Alternating hemiplegia of childhood |
P50993
(related)
|
H01210 | Hypomagnesemia |
P54710
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D015746 | D004077 | Abdominal Pain |
marker/mechanism
|
7427472
|
|
D058186 | D004077 | Acute Kidney Injury |
marker/mechanism
|
12243603
|
|
D000370 | D004077 | Ageusia |
marker/mechanism
|
16730151
|
|
D000743 | D004077 | Anemia, Hemolytic |
marker/mechanism
|
4124995
|
|
D000787 | D004077 | Angina Pectoris |
therapeutic
|
2912410
|
|
D000855 | D004077 | Anorexia |
marker/mechanism
|
3588469
4521669 11496033 |
|
D001145 | D004077 | Arrhythmias, Cardiac |
marker/mechanism
therapeutic |
3420
618505 758230 1166019 1259829 1413169 1449452 1696671 1958605 2535056 3498356 5009479 6173523 7070893 7193016 7319536 11794432 12361690 12365708 12804730 12939524 |
|
D001259 | D004077 | Ataxia |
marker/mechanism
|
5440585
|
|
D001281 | D004077 | Atrial Fibrillation |
marker/mechanism
therapeutic |
402273
1307536 1449452 1771805 1898998 2039889 2495120 2633456 3709557 4255107 4810020 6726272 6824397 6847447 7484490 7653451 7714233 7937281 8122604 8161643 9023092 10689846 11678058 11761419 15138971 15160669 15334025 17434635 19098677 19282313 |
|
D001282 | D004077 | Atrial Flutter |
marker/mechanism
therapeutic |
5020716
7937281 8407013 8957602 20093999 |
|
D018880 | D004077 | Atrial Premature Complexes |
marker/mechanism
|
66122
|
|
D054537 | D004077 | Atrioventricular Block |
marker/mechanism
|
66122
319642 4255107 5020716 5030650 5031735 7226934 9505930 15334025 19028199 |
|
D001321 | D004077 | Autistic Disorder |
marker/mechanism
|
14585753
|
|
D001327 | D004077 | Autoimmune Diseases |
therapeutic
|
21441909
|
|
C535438 | D004077 | Bidirectional tachycardia |
marker/mechanism
|
4781244
6831957 7082511 7451788 7782630 9023092 9548072 |
|
D001919 | D004077 | Bradycardia |
marker/mechanism
|
82842
1997018 2495120 2715933 3334799 7070893 7226934 7346740 8161643 9429088 9674488 15334025 16032632 |
|
D001927 | D004077 | Brain Diseases |
marker/mechanism
|
7714233
|
|
D002037 | D004077 | Bundle-Branch Block |
marker/mechanism
|
97948
2495120 3729077 16032632 |
|
D006332 | D004077 | Cardiomegaly |
marker/mechanism
|
19687166
|
|
D009202 | D004077 | Cardiomyopathies |
therapeutic
|
589261
7103641 7573102 |
|
D002311 | D004077 | Cardiomyopathy, Dilated |
therapeutic
|
2722306
9838955 |
|
D002318 | D004077 | Cardiovascular Diseases |
therapeutic
|
9846537
|
|
D002526 | D004077 | Cerebellar Diseases |
marker/mechanism
|
5440585
|
|
D002598 | D004077 | Chagas Cardiomyopathy |
therapeutic
|
16764726
|
|
D002639 | D004077 | Cheyne-Stokes Respiration |
marker/mechanism
|
5440585
|
|
D002819 | D004077 | Chorea |
marker/mechanism
|
3382897
6726272 10495059 |
|
D003072 | D004077 | Cognition Disorders |
marker/mechanism
|
8134536
17078259 |
|
D003117 | D004077 | Color Vision Defects |
marker/mechanism
|
1771077
6654298 6973045 7283806 7816418 12386084 |
|
D003128 | D004077 | COMA |
marker/mechanism
|
5440585
|
|
D003221 | D004077 | Confusion |
marker/mechanism
|
1965965
6847447 |
|
D003324 | D004077 | Coronary Artery Disease |
therapeutic
|
758516
|
|
D003329 | D004077 | Coronary Vasospasm |
marker/mechanism
|
7810184
|
|
D003645 | D004077 | Death, Sudden |
marker/mechanism
|
10437870
|
|
D003680 | D004077 | Deglutition Disorders |
marker/mechanism
|
2039889
3742345 |
|
D003693 | D004077 | Delirium |
marker/mechanism
|
618505
8134536 |
|
D003704 | D004077 | Dementia |
marker/mechanism
|
17326274
|
|
D003866 | D004077 | Depressive Disorder |
marker/mechanism
|
6719535
7714233 8077083 |
|
D003967 | D004077 | Diarrhea |
marker/mechanism
|
9220047
20466255 |
|
D004244 | D004077 | Dizziness |
marker/mechanism
|
11678058
|
|
D056486 | D004077 | Drug-Induced Liver Injury |
marker/mechanism
|
1479182
22331495 |
|
D062787 | D004077 | Drug Overdose |
marker/mechanism
|
9667338
|
|
D064420 | D004077 | Drug-Related Side Effects and Adverse Reactions |
marker/mechanism
|
11808
140932 533394 702246 3334799 3976714 4003251 4255107 4418514 4668629 4781244 5020716 5030650 5071802 6409240 7110822 7226934 7283806 7320392 7837314 8113441 8338474 8993214 9220047 9357092 9548072 9727817 12701389 16594604 20466255 |
|
D004374 | D004077 | Ductus Arteriosus, Patent |
therapeutic
|
6880719
7070893 |
|
D055154 | D004077 | Dysphonia |
marker/mechanism
|
2039889
|
|
D004417 | D004077 | Dyspnea |
marker/mechanism
|
12078937
16032632 |
|
D001068 | D004077 | Eating Disorders |
marker/mechanism
|
618505
|
|
D004437 | D004077 | Ebstein Anomaly |
therapeutic
|
4819255
|
|
D004487 | D004077 | Edema |
marker/mechanism
|
16032632
|
|
D007172 | D004077 | Erectile Dysfunction |
marker/mechanism
|
9554348
|
|
D058447 | D004077 | Eye Pain |
marker/mechanism
|
1532600
|
|
D005221 | D004077 | Fatigue |
marker/mechanism
|
11496033
|
|
D005315 | D004077 | Fetal Diseases |
therapeutic
|
14745562
|
|
D006212 | D004077 | Hallucinations |
marker/mechanism
|
517886
6847447 |
|
D006323 | D004077 | Heart Arrest |
marker/mechanism
|
1958605
2912410 3179159 3544756 3663292 4251179 5764970 6992826 9667338 12921933 |
|
D006327 | D004077 | Heart Block |
marker/mechanism
|
1997018
5009479 5031735 5440585 5823016 6831957 7082511 7346740 7398422 9493887 12181225 |
|
D006331 | D004077 | Heart Diseases |
marker/mechanism
therapeutic |
588806
6695683 |
|
D006333 | D004077 | Heart Failure |
marker/mechanism
therapeutic |
517886
642984 1632402 1696671 2277481 3004211 3075397 3813644 4255107 6630284 6704950 6798885 6847447 7202043 7359592 7398145 7560247 7714233 7728813 8161643 8409069 8561216 8614419 9123633 9818470 11477829 11496033 12365708 12723015 16764726 19282313 21516734 |
|
D006505 | D004077 | Hepatitis |
marker/mechanism
|
12243603
|
|
D006947 | D004077 | Hyperkalemia |
marker/mechanism
|
1997018
16032632 |
|
D006973 | D004077 | Hypertension |
therapeutic
|
9772400
11016824 |
|
D007008 | D004077 | Hypokalemia |
marker/mechanism
|
1259829
2311237 6603084 |
|
D007022 | D004077 | Hypotension |
marker/mechanism
|
9429088
11016824 |
|
D007232 | D004077 | Infant, Newborn, Diseases |
marker/mechanism
|
7070893
|
|
D007235 | D004077 | Infant, Premature, Diseases |
therapeutic
|
6880719
|
|
D007859 | D004077 | Learning Disorders |
marker/mechanism
|
6415737
|
|
D053609 | D004077 | Lethargy |
marker/mechanism
|
3588469
|
|
D008133 | D004077 | Long QT Syndrome |
marker/mechanism
|
3271390
|
|
D008173 | D004077 | Lung Diseases, Obstructive |
therapeutic
|
11150940
|
|
D008275 | D004077 | Magnesium Deficiency |
marker/mechanism
|
2311237
|
|
D008569 | D004077 | Memory Disorders |
marker/mechanism
|
618505
6415737 |
|
D001523 | D004077 | Mental Disorders |
marker/mechanism
|
1735661
3565623 |
|
D008944 | D004077 | Mitral Valve Insufficiency |
therapeutic
|
5440585
6847447 9838955 |
|
D019964 | D004077 | Mood Disorders |
marker/mechanism
|
618505
|
|
D009325 | D004077 | Nausea |
marker/mechanism
|
2495120
3709557 6726272 9220047 11496033 11678058 16032632 20466255 |
|
D009369 | D004077 | Neoplasms |
therapeutic
|
18701493
|
|
D009410 | D004077 | Nerve Degeneration |
marker/mechanism
|
12562015
|
|
D009759 | D004077 | Nystagmus, Pathologic |
marker/mechanism
|
5440585
|
|
D000857 | D004077 | Olfaction Disorders |
marker/mechanism
|
16730151
|
|
D009901 | D004077 | Optic Nerve Diseases |
marker/mechanism
|
12365708
|
|
D010146 | D004077 | Pain |
marker/mechanism
|
4687265
|
|
D010259 | D004077 | Paranoid Disorders |
marker/mechanism
|
3588469
|
|
D010554 | D004077 | Personality Disorders |
marker/mechanism
|
7714233
|
|
D011596 | D004077 | Psychomotor Disorders |
marker/mechanism
|
11496033
|
|
D011654 | D004077 | Pulmonary Edema |
therapeutic
|
6374055
|
|
D051437 | D004077 | Renal Insufficiency |
marker/mechanism
|
9155634
|
|
D012206 | D004077 | Rhabdomyolysis |
marker/mechanism
|
11149552
12243603 |
|
D012640 | D004077 | Seizures |
marker/mechanism
|
1665475
1958605 6405441 6426855 |
|
D020018 | D004077 | Sexual Dysfunctions, Psychological |
marker/mechanism
|
2952803
7416947 |
|
D012804 | D004077 | Sick Sinus Syndrome |
marker/mechanism
|
1132120
6409240 7206114 |
|
D012848 | D004077 | Sinoatrial Block |
marker/mechanism
|
7405294
|
|
D013375 | D004077 | Substance Withdrawal Syndrome |
marker/mechanism
|
9207619
|
|
D013610 | D004077 | Tachycardia |
marker/mechanism
therapeutic |
1997018
2429280 3859260 6842789 16128378 |
|
D013612 | D004077 | Tachycardia, Ectopic Atrial |
marker/mechanism
|
3138054
|
|
D013613 | D004077 | Tachycardia, Ectopic Junctional |
marker/mechanism
|
7226934
9493887 12181225 |
|
D013614 | D004077 | Tachycardia, Paroxysmal |
marker/mechanism
|
5823016
7226934 7346740 |
|
D013617 | D004077 | Tachycardia, Supraventricular |
marker/mechanism
therapeutic |
66122
2189795 3709557 3776866 3982906 4255107 5764970 6831957 6859944 7082511 7226934 7346740 7398422 7451788 14745562 20093999 |
|
D017180 | D004077 | Tachycardia, Ventricular |
marker/mechanism
|
61518
1013176 2446278 3138054 4255107 4711856 4810020 4954152 4965975 5764970 6173530 7226934 7398422 7837314 8444004 9220047 11761419 15138971 |
|
D016171 | D004077 | Torsades de Pointes |
marker/mechanism
|
1743800
6695683 |
|
D014277 | D004077 | Trigeminal Neuralgia |
marker/mechanism
|
758516
|
|
D018754 | D004077 | Ventricular Dysfunction |
therapeutic
|
3946163
|
|
D018487 | D004077 | Ventricular Dysfunction, Left |
therapeutic
|
7728813
9207619 |
|
D014693 | D004077 | Ventricular Fibrillation |
marker/mechanism
|
4088942
5041936 5676466 5764970 7110822 7202043 7295427 8532572 9667338 |
|
D018879 | D004077 | Ventricular Premature Complexes |
marker/mechanism
|
66122
4015280 4255107 4711856 4810020 5676466 5764970 7226934 11761419 |
|
D014786 | D004077 | Vision Disorders |
marker/mechanism
|
618505
1771077 8113441 9512168 11151114 12365708 16730151 20466255 |
|
D014839 | D004077 | Vomiting |
marker/mechanism
|
2495120
6726272 9220047 11678058 |
|
D015431 | D004077 | Weight Loss |
marker/mechanism
|
4521669
6847447 |